Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies
Neurol 92:663-674, Johansen, A.,et al, 2019
Community-Acquired Bacterial Meningitis in Adults with Cancer or a History of Cancer
Neurol 86:860-866, Costerus, J.M.,et al, 2016
Bacterial and Fungal Meningitis in Patients With Cancer
Neurol 70:943-947, Safdieh,J.E.,et al, 2008
Risk Factors of Cerebral Vein and Sinus Thrombosis
Front Neurol Neurosci 23:23-54, de Freitas, G.R. & Bogousslavsky, J., 2008
Neurologic Emergencies in Cancer Patients
Neurol Clin 16:1-37, Schiff,D.,et al, 1998
Neurologic Complications of Systemic Cancer
In Neurologic Clinics 3:729-750, Patchell,R.A.&Posner,J.B., 1985
Neurotoxicity of Commonly Used Antineoplastic Agents
NEJM 291:75, 1271974., Weiss,H.,et al, 1974
Infiltration of the Leptomeninges by Systemic Cancer:a Clinical & Pathologic Study
Arch Neurol 30:122, Olson,M.E.,et al, 1974
Neurological Complications of Systemic Cancer
Med Clin North Am 55:625, Posner,J., 1971